Literature DB >> 23791891

Antifibrotic effect of synthetic Smad/Sp1 chimeric decoy oligodeoxynucleotide through the regulation of epithelial mesenchymal transition in unilateral ureteral obstruction model of mice.

Woo Jung Sung1, Kyung-Hyun Kim, Yong-Jin Kim, Young-Chae Chang, In Hee Lee, Kwan-Kyu Park.   

Abstract

Renal tubulointerstitial fibrosis is considered to be a common final pathway related to the progressive loss of renal function in chronic kidney disease. It is characterized by the excessive accumulation of extracellular matrix through the pivotal role of epithelial-mesenchymal transition. Transforming growth factor-β1 is postulated to play a central role in renal fibrosis via a downstream pathway such as Smad. Specificity protein 1 (Sp1), which is another transcription factor, is also involved in the basal expression of extracellular matrix. In this study, we investigate the effect of Smad decoy oligodeoxynucleotides (ODN) and Sp1 decoy ODN in unilateral ureteral obstruction induced renal fibrosis in mice. Furthermore, the effectiveness of the newly designed chimeric decoy ODN, which contains both Smad and Sp1 binding sequences in one decoy molecule (Smad/Sp1 chi decoy ODN), was demonstrated. The expression of fibrosis and inflammatory related cytokines and products of fibrosis were ameliorated in the Smad, Sp1 and chimeric decoy ODN treated groups compared with the scrambled decoy ODN treated group. Epithelial-mesenchymal transition was suppressed by the Smad, Sp1 and Smad/Sp1 chi decoy ODN. Immunohistochemistry and Western-blot analysis revealed that Smad/Sp1 chi decoy ODN showed a more significant inhibitory effect on fibrosis and EMT compared with Smad and Sp1 decoy ODNs. These results support the efficacy of Smad/Sp1 chi decoy compared with a single Smad or Sp1 decoy ODNs in preventing renal fibrosis induced by unilateral ureteral obstruction.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decoy oligodeoxynucloeotide; EMT; Renal fibrosis; Smad; Sp1; TGF-β1

Mesh:

Substances:

Year:  2013        PMID: 23791891     DOI: 10.1016/j.yexmp.2013.06.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  11 in total

1.  Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.

Authors:  Sun-Jae Lee; Kyung-Hyun Kim; Sok Cheon Pak; Yu-Na Kang; Ghil-Suk Yoon; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets.

Authors:  Wenshan Lv; George W Booz; Yangang Wang; Fan Fan; Richard J Roman
Journal:  Eur J Pharmacol       Date:  2017-12-08       Impact factor: 4.432

Review 3.  Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?

Authors:  Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Transcription Factor Specificity Protein 1 Regulates Inflammation and Fibrin Deposition in Nasal Polyps Via the Regulation of microRNA-125b and the Wnt/β-catenin Signaling Pathway.

Authors:  Li Song; Xi Wang; Xiangyang Qu; Chao Lv
Journal:  Inflammation       Date:  2022-01-06       Impact factor: 4.092

5.  Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.

Authors:  Yi Zhang; Hai-xuan Chen; Shu-yan Zhou; Shao-xiang Wang; Kai Zheng; Dan-dan Xu; Yu-ting Liu; Xiao-yan Wang; Xiao Wang; Hai-Zhao Yan; Li Zhang; Qiu-ying Liu; Wan-qun Chen; Yi-fei Wang
Journal:  Mol Cancer       Date:  2015-03-07       Impact factor: 27.401

Review 6.  Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis.

Authors:  Sung Won Youn; Kwan-Kyu Park
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

7.  Sesamin Ameliorates High-Fat Diet-Induced Dyslipidemia and Kidney Injury by Reducing Oxidative Stress.

Authors:  Ruijuan Zhang; Yan Yu; Jianjun Deng; Chao Zhang; Jinghua Zhang; Yue Cheng; Xiaoqin Luo; Bei Han; Haixia Yang
Journal:  Nutrients       Date:  2016-05-09       Impact factor: 5.717

8.  SP1 and UTE1 Decoy ODNs inhibit activation and proliferation of hepatic stellate cells by targeting tissue inhibitors of metalloproteinase 1.

Authors:  Dong Jia; Yi-Ran Ni; Yan-Qiong Zhang; Chun Rao; Jun Hou; He-Qing Tang; Chang-Bai Liu; Jiang-Feng Wu
Journal:  Cell Biosci       Date:  2016-05-10       Impact factor: 7.133

9.  Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl₄-Induced Hepatic Fibrosis Animal Model.

Authors:  Mi-Gyeong Gwon; Jung-Yeon Kim; Hyun-Jin An; Woon-Hae Kim; Hyemin Gu; Min-Kyung Kim; Sok Cheon Park; Kwan-Kyu Park
Journal:  Molecules       Date:  2018-08-10       Impact factor: 4.411

10.  Melatonin Prevents Transforming Growth Factor-β1-Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms.

Authors:  Jung-Yeon Kim; Jae-Hyung Park; Eon Ju Jeon; Jaechan Leem; Kwan-Kyu Park
Journal:  Antioxidants (Basel)       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.